---
title: "VREOF: Vireo Growth’s strong revenue growth supports price target of $45.00"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295672905.md"
description: "Vireo Growth (OTCQX: VREOF) reported strong Q2 2026 financial results, with GAAP revenue reaching $209.3 million, a 335% year-over-year increase driven by M&A transactions. Pro forma revenue stood at $254.9 million. Analyst Tom Kerr, CFA, notes that this robust growth supports a price target of $45.00."
datetime: "2026-08-12T13:32:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295672905.md)
  - [en](https://longbridge.com/en/news/295672905.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295672905.md)
generator: "portal-rs"
---

# VREOF: Vireo Growth’s strong revenue growth supports price target of $45.00

By Tom Kerr, CFA OTCQX: VREOF READ THE FULL VREOF RESEARCH REPORT 2nd Quarter 2026 Financial Results On August 11, 2026, Vireo (OTCQX: VREOF) released 2nd quarter 2026 financial results, which showed strong revenue growth on a GAAP, Pro Forma, and organic basis. Vireo reported Q2 GAAP revenue of $209.3 million, up 335% year-over-year, driven primarily by recently completed M&A transactions. Pro forma revenue was $254.9 million, reflecting the...

### Related Stocks

- [VREOF.US](https://longbridge.com/en/quote/VREOF.US.md)

## Related News & Research

- [OKLO stock slips overnight: This analyst sees 29% upside, but retail turns bearish](https://longbridge.com/en/news/298536553.md)
- [Chime Financial (CHYM) Could Be 6% Undervalued After Stride Deal And Outlook Lift](https://longbridge.com/en/news/298483669.md)
- [08:45 ETMicah Parsons Joins RejuvStem as Investor and Brand Ambassador](https://longbridge.com/en/news/298321840.md)
- [Bullen Ultrasonics Named 2026 IndustryWeek Best Plants Award Winner](https://longbridge.com/en/news/298438514.md)
- [CN Energy Group files audited FY2025 results amendment, reports USD 11.14 million net loss](https://longbridge.com/en/news/298642269.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**